Cochrane Review: Sedatives for opioid withdrawal in newborn infants

Zusammenfassung

Sedativa für den Opioid‐Entzug bei Neugeborenen - Zankl, A - 2021 \| Cochrane Library [Skip to Content](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002053.pub4/full/de#main-content) [Close cookies message](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002053.pub4/full/de#) Cookies Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do s

Kerninformationen

://www.cochranelibrary.com/en/about/about-cochrane-reviews) Review - Intervention - [New search](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002053.pub4/information/de#history) - [Conclusions changed](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002053.pub4/informatio...

determine which type of sedative is most effective and safe for NAS due to withdrawal from opioids. ### Search methods We ran an updated search on 17 September 2020 in CENTRAL via CRS Web and MEDLINE via Ovid. We searched clinical trials databases, conference proceedings and the reference lists o...

he certainty of the evidence. ### Main results We included 10 trials (581 infants) with NAS secondary to maternal opioid use in pregnancy. There were multiple comparisons of different sedatives and regimens. There were limited data available for use in sensitivity analysis of studies at low risk o...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen